Brief report: Impact of option B+ on the infant PMTCT cascade in Lilongwe, Malawi

Maria H. Kim, Saeed Ahmed, Mina C. Hosseinipour, Xiaoying Yu, Chi Nguyen, Frank Chimbwandira, Mary E. Paul, Peter N. Kazembe, Elaine J. Abrams

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


This observational study compared uptake of infant prevention of mother-to-child transmission of HIV services pre/post implementation of Option B+ in Lilongwe, Malawi. There were 845 (pre) and 998 (post) births. Post-B+, infants had longer median predelivery maternal antiretroviral therapy {62 days [interquartile range (IQR): 38-94] pre-B+ vs. 95 days [IQR: 61-131] post-B+; P < 0.0001} and improved polymerase chain reaction testing (82.0% vs. 86.5%; P 0.01) at younger median age [7.6 weeks (IQR: 6.6-10.9) vs. 6.9 (IQR: 6.4-8.1); P < 0.0001]. Proportion testing polymerase chain reaction positive decreased (4.6% vs. 2.6%; P 0.03). Proportion of HIV-infected infants starting antiretroviral therapy (75% vs. 77.3%) and age at initiation [19.7 weeks (IQR: 15.4-31.1) vs. 16 (IQR: 13.3-17.9)] remained unchanged. These findings suggest modest improvements in infant care with Option B+.

Original languageEnglish (US)
Pages (from-to)99-103
Number of pages5
JournalJournal of Acquired Immune Deficiency Syndromes
Issue number1
StatePublished - Sep 1 2015
Externally publishedYes


  • Africa
  • HIV
  • Malawi
  • Option B+
  • antiretroviral
  • early infant diagnosis

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)


Dive into the research topics of 'Brief report: Impact of option B+ on the infant PMTCT cascade in Lilongwe, Malawi'. Together they form a unique fingerprint.

Cite this